NEW YORK (GenomeWeb) – MDxHealth announced today that it has been awarded a US General Services Administration contract to supply its ConfirmMDx prostate cancer test to the Department of Veterans Affairs.

According to the company, the five-year contract provides coverage of ConfirmMDx testing at the Medicare rate for veterans with the VA health system beginning February 1. Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.